Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2012
High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic reviewE Cholongitas, G V Papatheodoridis
Journal of Viral Hepatitis|July 3, 2004
Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic optionsG V Papatheodoridis, E Cholongitas
Alimentary Pharmacology & Therapeutics|February 21, 2008
Review article: novel therapeutic options for chronic hepatitis CE Cholongitas, G V Papatheodoridis
Alimentary Pharmacology & Therapeutics|December 5, 2013
Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney diseaseC Pipili, E Cholongitas, G Papatheodoridis
Hippokratia|August 8, 2022
Abdominal aorta aneurysm endograft infection mimicking bacteraemic urinary tract infectionN Papazoglou, M Samarkos, C Vergadis, et al.
World Journal of Gastroenterology|January 5, 2007
New insights into the coagulopathy of liver disease and liver transplantationM Senzolo, P Burra, E Cholongitas, et al.
World Journal of Gastroenterology|August 1, 2007
Veno occlusive disease: update on clinical managementM Senzolo, G Germani, E Cholongitas, et al.
American Journal of Hematology|November 20, 2004
Type I Gaucher disease with severe skeletal destruction, extraosseous extension, and monoclonal gammopathyA Kaloterakis, E Cholongitas, E Pantelis, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2012
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuationE Cholongitas, T Vasiliadis, N Antoniadis, et al.
Journal of Viral Hepatitis|January 16, 2008
Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infectionG V Papatheodoridis, N Chrysanthos, E Hadziyannis, et al.
Pageof 4